NOVOTTF-100A SYSTEM
FDA premarket approval P100034/S004 · decided 2013-08-08
Approval details
- PMA number
- P100034
- Supplement
- S004
- Supplement type
- Normal 180 Day Track
- Supplement reason
- Change Design/Components/Specifications/Material
- Trade name
- NOVOTTF-100A SYSTEM
- Generic name
- Stimulator, low electric field, tumor treatment
- Applicant
- Novocure, GmbH
- Date received
- 2013-04-08
- Decision date
- 2013-08-08
- Days to decision
- 122 days
- Decision code
- APPR
- Product code
- NZK
- Advisory committee
- Neurology
- Expedited review
- No
- Location
- Baar
- Statement
- APPROVAL FOR TRANSFERRING THE RESPONSIBILITY OF PERFORMING THE NOVOTAL TRANSDUCER ARRAY MAPPING FROM NOVOCURES STAFF TO TRAINED PHYSICIANS RESPONSIBLE FOR PRESCRIBING THE DEVICE.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.